000 01474 a2200361 4500
005 20250515031139.0
264 0 _c20060905
008 200609s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2006.06.1622
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWöhrer, Stefan
245 0 0 _aTreatment of localized primary gastric lymphoma.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJun 2006
300 _a2682; author reply 2682-3 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aHelicobacter Infections
_xdrug therapy
650 0 4 _aHelicobacter pylori
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xdrug therapy
650 0 4 _aLymphoma, Non-Hodgkin
_xdrug therapy
650 0 4 _aPatient Selection
650 0 4 _aRadiotherapy Dosage
650 0 4 _aStomach Neoplasms
_xdrug therapy
700 1 _aTroch, Marlene
700 1 _aRaderer, Markus
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 24
_gno. 17
_gp. 2682; author reply 2682-3
856 4 0 _uhttps://doi.org/10.1200/JCO.2006.06.1622
_zAvailable from publisher's website
999 _c16358992
_d16358992